Two women laugh together outside
Two women laugh together outside

Our Mission: More life for people with cancer

Our work doesn’t stop when the research is done or the discovery is made. The burden of cancer is vast, but so are our aspirations to redefine how this disease is treated.

Our Science

Woman in a lab looks into a microscope
Woman in a lab looks into a microscope

Developing Innovative Therapies

We want to enhance the current standard of care and quality of care for difficult-to-treat and debilitating types of cancer.

Our Team

MorphoSys colleagues during a Leadership Training
MorphoSys colleagues during a Leadership Training

Fostering an Inclusive Workplace

We are an equal opportunity employer committed to creating an inclusive, collaborative and vibrant environment for our team.


Icon of three people

Talented employees in the U.S. and Germany

Icon of a woman
61 %

Women working at MorphoSys

icon of the world

Nationalities represented across our company

Icon of a winner
44 %

Leadership positions held by women

Events & Conferences

05 Dec 2023

The JMP Securities Hematology and Oncology Summit (Virtual)

Our CEO, Jean-Paul Kress, M.D., will present the company during a Webcast.

Date: Tuesday, December 5
Time: 12.30pm ET

Access Webcast

11 Dec 2023

ASH 2023 Investor Event with Medical Experts

The event will highlight pelabresib’s potential in first-line myelofibrosis with a comprehensive overview of the Phase 3 MANIFEST-2 trial results, which will be presented during an oral presentation at ASH 2023 on Sunday December 10. There will be live presentations from and a Q&A opportunity with MorphoSys management and leading medical experts. 

Monday, December 11, 7:00 a.m. – 8:30 a.m. PST  (10:00 a.m. - 11:30 a.m. EST / 4:00 p.m. - 5:30 p.m. CET)

Webcast Presentation